Insider · CIK 0001705851
David P Strauss
officer
Files at LIN (LINDE PLC). First filing Dec 17, 2024, latest May 20, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $3.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LIN: LINDE PLC
LINOct 9, 2026 · close 483.73
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | LINDE PLC | $908k 1,987 shares | -8% | +11% from low-5% from high | |
| 60Notable | LINDE PLC | $1.2M 2,477 shares | -66% | - | |
| 47Moderate | LINDE PLC | $963k 2,218 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 16, 2025 | LIN LINDE PLC | SOpen-market sale Ordinary Sharesindirect: In Family Trust | -1,987 | $457.04 | $908k | 22,639 | May 20, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | MOption exercise Ordinary Shares | +1,180 | $0.00 | $0 | 2,480 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | FTax withholding Ordinary Shares | -576 | $468.77 | $270k | 1,904 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | MOption exercise Ordinary Shares | +3,530 | $0.00 | $0 | 5,434 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | FTax withholding Ordinary Shares | -1,806 | $468.77 | $846k | 3,628 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | MOption exercise Ordinary Shares | +2,171 | $0.00 | $0 | 5,799 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | FTax withholding Ordinary Shares | -1,110 | $468.77 | $521k | 4,689 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | AGrant or award Performance Share Units (ROC)derivative | +3,530 | $0.00 | $0 | 3,530 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | MOption exercise Performance Share Units (ROC)derivative | -3,530 | $0.00 | $0 | 0 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | AGrant or award Performance Share Units (RTSR)derivative | +2,171 | $0.00 | $0 | 2,171 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | MOption exercise Performance Share Units (RTSR)derivative | -2,171 | $0.00 | $0 | 0 | Mar 11, 2025 |
| Mar 10, 2025 | LIN LINDE PLC | MOption exercise Restricted Stock Unitsderivative | -1,180 | $0.00 | $0 | 0 | Mar 11, 2025 |
| Mar 7, 2025 | LIN LINDE PLC | AGrant or award Restricted Stock Unitsderivative | +1,278 | $0.00 | $0 | 1,278 | Mar 11, 2025 |
| Mar 7, 2025 | LIN LINDE PLC | AGrant or award Stock Options (right to buy)derivative | +8,973 | $0.00 | $0 | 8,973 | Mar 11, 2025 |
| Mar 3, 2025 | LIN LINDE PLC | MOption exercise Ordinary Shares | +7,545 | $154.00 | $1.2M | 8,845 | Mar 4, 2025 |
| Mar 3, 2025 | LIN LINDE PLC | FTax withholding Ordinary Shares | -5,068 | $469.95 | $2.4M | 3,777 | Mar 4, 2025 |
| Mar 3, 2025 | LIN LINDE PLC | SOpen-market sale Ordinary Shares | -2,477 | $469.74 | $1.2M | 1,300 | Mar 4, 2025 |
| Mar 3, 2025 | LIN LINDE PLC | MOption exercise Stock Options (right to buy)derivative | -7,545 | $0.00 | $0 | 7,545 | Mar 4, 2025 |
| Dec 20, 2024 | LIN LINDE PLC | GGift Ordinary Shares | -24,626 | $0.00 | $0 | 1,300 | Dec 26, 2024 |
| Dec 20, 2024 | LIN LINDE PLC | GGift Ordinary Sharesindirect: In Family Trust | +24,626 | $0.00 | $0 | 24,626 | Dec 26, 2024 |
| Dec 16, 2024 | LIN LINDE PLC | SOpen-market sale Ordinary Shares | -2,218 | $434.35 | $963k | 25,926 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.